(Q39972410)

16 September 2017

Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage (English)

1 reference

16 September 2017

1 reference

Martin Barth

1

1 reference

16 September 2017

Pablo Pena

2

1 reference

16 September 2017

Marcel Seiz

3

1 reference

16 September 2017

Claudius Thomé

4

1 reference

16 September 2017

Elke Muench

5

1 reference

16 September 2017

Stephan Weidauer

6

1 reference

16 September 2017

Elke Hattingen

7

1 reference

16 September 2017

Hidetoshi Kasuya

8

1 reference

16 September 2017

Peter Schmiedek

9

1 reference

16 September 2017

23 February 2011

1 reference

British Journal of Neurosurgery

16 September 2017

1 reference

16 September 2017

25

1 reference

16 September 2017

6

1 reference

16 September 2017

677-683

1 reference

Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study

16 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

Evidence-based cerebral vasospasm management.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

Use of endovascular coil embolization and surgical clip occlusion for cerebral artery aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688697.2010.548878

10.3109/02688697.2010.548878

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference